5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 46.84▲ | 46.38▲ | 46.09▲ | 44.59▲ | 38.58▲ |
MA10 | 46.49▲ | 46.05▲ | 46.20▲ | 41.67▲ | 31.26▲ |
MA20 | 46.29▲ | 46.07▲ | 45.69▲ | 39.43▲ | 27.53▲ |
MA50 | 45.86▲ | 44.90▲ | 42.77▲ | 30.59▲ | N/A |
MA100 | 46.00▲ | 42.22▲ | 40.27▲ | 27.27▲ | N/A |
MA200 | 45.23▲ | 40.06▲ | 35.62▲ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.098▲ | 0.012▲ | -0.095▼ | 0.515▲ | 2.327▲ |
RSI | 66.605▲ | 61.428▲ | 61.252▲ | 84.331▲ | 81.345▲ |
STOCH | 93.169▲ | 63.655 | 66.735 | 92.933▲ | 90.973▲ |
WILL %R | -15.254▲ | -8.333▲ | -4.403▲ | -5.000▲ | -2.413▲ |
CCI | 171.188▲ | 149.060▲ | 98.657 | 151.531▲ | 177.618▲ |
Thursday, August 14, 2025 04:45 AM
(PVLA) on Thursday reported a loss of $9.5 million in its second quarter. The Wayne, Pennsylvania-based company said it had a loss of 86 cents per share. The results did not meet Wall Street ...
|
Thursday, August 14, 2025 04:42 AM
Phase 3 SELVA trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic malformations completed enrollment, exceeding enrollment target by over 25%; top-line ...
|
Tuesday, August 12, 2025 01:15 PM
The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is still trading at three-year highs, despite current market volatility, in response to breakthrough innovations and increased deals involving biotech ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 47.12 | 47.97 | 44.245 | 47.30 | 190,700 |
14/08/25 | 43.83 | 47.50 | 41.71 | 46.10 | 205,200 |
13/08/25 | 43.49 | 46.24 | 42.995 | 44.64 | 130,933 |
12/08/25 | 41.56 | 44.039 | 40.92 | 43.21 | 119,100 |
11/08/25 | 41.00 | 41.72 | 40.22 | 41.71 | 78,000 |
08/08/25 | 39.30 | 41.00 | 38.95 | 40.90 | 106,135 |
07/08/25 | 39.12 | 39.185 | 37.33 | 39.05 | 75,100 |
06/08/25 | 38.80 | 39.40 | 37.50 | 39.07 | 242,700 |
05/08/25 | 37.26 | 37.79 | 36.93 | 37.52 | 57,112 |
04/08/25 | 36.79 | 37.825 | 36.00 | 37.20 | 74,853 |
|
|
||||
|
|
||||
|
|